PLSM

Pulsenmore Ltd

1.74

Oct 28 • 10:41 AM ET -0.05 (-2.79%)

Healthcare Medical Devices Israel Nano NASD

Peers: BFLY NNOX HSCS IVF IRTC DRIO IRIX MODD CTSO SINT

Index	-
Market Cap	13.95M
Enterprise Value	2.06M
Income	-9.35M
Sales	12.89M
Book/sh	2.49
Cash/sh	2.92
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	63
IPO	Jan 21, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	1.08
P/B	0.70
P/C	0.60
P/FCF	-
EV/EBITDA	-
EV/Sales	0.16
Quick Ratio	1.69
Current Ratio	1.84
Debt/Eq	0.71
LT Debt/Eq	0.01
Option/Short	No / Yes

EPS (ttm)	-1.44
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	13.21% -1.94%
Sales past 3/5Y	14.32% -
EPS Y/Y TTM	24.28%
Sales Y/Y TTM	406.71%
EPS Q/Q	-77.35%
Sales Q/Q	80.08%
Earnings	Aug 31 BMO
EPS/Sales Surpr.	- -

Insider Own	41.37%
Insider Trans	0.00%
Inst Own	5.93%
Inst Trans	1.60%
ROA	-26.98%
ROE	-48.74%
ROIC	-57.23%
Gross Margin	81.24%
Oper. Margin	-33.20%
Profit Margin	-72.48%
SMA20	-8.90%
SMA50	-24.13%
SMA200	-53.57%
Trades

Shs Outstand	6.50M
Shs Float	4.70M
Short Float	0.06%
Short Ratio	0.04
Short Interest	0.00M
52W High	12.97 -86.58%
52W Low	1.69 2.96%
Volatility	6.54% 9.70%
ATR (14)	0.18
RSI (14)	32.20
Beta	-
Rel Volume	0.54
Avg Volume	61.04K
Volume	7,553

Perf Week	-2.25%
Perf Month	-20.55%
Perf Quarter	-50.00%
Perf Half Y	-50.99%
Perf YTD	-81.59%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	1.79
Price	1.74
Change %	-2.79%

Oct-13-26 07:00AM	Pulsenmore Strengthens U.S. Commercial Leadership, Appoints Med-Tech Veteran David Woods as Chief Commercial Officer (PR Newswire)
Sep-17-26 07:00AM	Pulsenmore Expands Its Fertility Platform into the UK (PR Newswire)
Sep-08-26 07:00AM	Pulsenmore Expands into Fertility Care: Completes CE European Registration of Home Ultrasound System for Follicular Monitoring (PR Newswire)
Aug-31-26 07:00AM	Pulsenmore Ltd. Announces Financial Results and Business Highlights for the First Half of 2026 (PR Newswire)
Aug-24-26 07:00AM	Pulsenmore Ltd. To Announce Financial Results and Business Highlights and Hold Conference Call for the First Half of 2026 (PR Newswire) -5.10%
07:00AM	Loading…
Aug-19-26 07:00AM	Pulsenmore Expands Its Home Ultrasound Activity in Israel: Ichilov Adopts the Technology, Expanding Access to At-Home Pregnancy Monitoring (PR Newswire)
Aug-17-26 07:00AM	Pulsenmore Receives Second AI Grant Within One Month: Israel Innovation Authority Approves $1.27 Million for SmartScan AI Program (PR Newswire)
Jul-13-26 08:53AM	Pulsenmore Shares Soar After Joining Israel's Healthcare AI Sandbox Programme (PLSM) (Investors Hub) -6.22%
07:00AM	Pulsenmore Selected for Israel Innovation Authority and Ministry of Health Program to Lead an $1 Million AI Development Project (PR Newswire)
Jun-25-26 08:00AM	Pulsenmore Announces Pricing of $7.5 Million Private Placement with a Single Healthcare Focused Institutional Investor (PR Newswire) -10.47%
Jun-24-26 11:45AM	Why Did PLSM Stock Surge More Than 200% Today? (Stocktwits) +93.26%
07:00AM	Pulsenmore Announces Strategic Partnership with Ouma Health to Expand Access to Remote Prenatal Care Across the United States (PR Newswire)
Mar-30-26 08:29AM	Pulsenmore Announces Full Year 2025 Financial Results and Webcast (PR Newswire)
Mar-25-26 08:00AM	Pulsenmore Announces Full Year 2025 Earnings Conference Call (PR Newswire) -5.51%
Feb-09-26 07:00AM	Pulsenmore Builds U.S. Momentum with Another Commercial Engagement Following FDA Clearance (PR Newswire)
07:13AM	Loading…
Feb-02-26 07:13AM	Pulsenmore Announces First Commercial Engagement with a Leading U.S.-Based Medical Center (PR Newswire)
Jan-26-26 07:30AM	Pulsenmore and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation (PR Newswire)
Jan-23-26 10:06AM	Pulsenmore to commence trading on Nasdaq (TipRanks)
Jan-21-26 07:30AM	Pulsenmore To Commence Trading on Nasdaq as It Expands FDA-authorized Home Prenatal Ultrasound Devices in the U.S. (PR Newswire)

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Guz-Lavi Racheli	Director	Oct 14 '26	Option Exercise	0.03	46,874	1,500	46,874	Oct 14 04:15 PM

Pulsenmore Ltd. engages in research and development, production, marketing, and sale of self-scan ultrasound devices for remote clinical diagnosis and screening. It also offers a mobile app that guides the patient through a self-scan and enables online consolation with a clinician; as well as a clinician dashboard that allows clinicians to review scans and interacts with the patient remotely. The company was founded by Elazar Sonnenschein on October 27, 2014 and is headquartered in Omer, Israel.

FounderDr. Elazar Sonnenschein

Chief Financial OfficerMr. Eran Hirsh

Vice President of R&DMr. Minelu Sonnenschein

Vice President of Software DevelopmentMr. Meir Shmouely

General Counsel & Company SecretaryMr. Michael Hamelsdorf

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PLSM

Pulsenmore Ltd

Upgrade your Finviz experience